Market Access Platform (MAP)

The right data at the right time to make the right drug pricing and reimbursement decision.

The Context Matters Market Access Platform (MAP) delivers the end-to-end solution to inform global market access strategy. Used across pharmaceutical and biotechnology organizations by Research & Development, HEOR, market access, pricing, brand, and other collaborating teams, the MAP delivers a unified approach to apply evidence-driven decision making from early pipeline to product introduction and franchise expansion.

The standard MAP configuration provides all users with access to a broad view across 53 different disease conditions and the leading global health technology assessment (HTA) and regulatory agencies. A customizable solution, customers can add data packages for disease conditions, agencies, special groupings of drugs, historical data, or even focus on a specific group of diseases.  


The MAP provides an expansive view of the reimbursement and regulatory landscape needed to rapidly respond to market dynamics.

  • Monitor the industry and competitor activity

  • Detect potential trends and market opportunities

  • Identify key drivers in HTA decisions

  • Collaborate and communicate from a shared context facilitated by in-system tools and user-support programs

Capability Modules

Optional capability modules enable users to drill deeper into specific vertical areas—defined by disease condition or therapeutic area—with expanded data and integrated analytic tools for in-depth analysis of reimbursement, clinical, and regulatory activities.

Clinical Strategy Module

Inform clinical trials, identify comparators, and run analysis to uncover what agencies value—clinically based intelligence to support a positive reimbursement decision. 

Economic Strategy Module

Examine how models have succeeded and failed, identify economic comparators considered acceptable, review the time horizon, examine ICER/QALY values, evaluate implied thresholds, and gain insights on cost-effectiveness.

Regulatory Strategy

Drill deep with a focus on regulatory specific decisions or to analyze across regulatory and HTA decisions to create an optimal strategic approach for approval and positive reimbursement decisions. 

Search & Compare


Agency, Disease Condition, Drug, and Company Snapshots make it easy to quickly get a preview of all of the information available for an entity.

Compute & Visualize


Aggregations, groupings, and measures that are so easy, it doesn’t even feel like math.

Communicate & Collaborate


Sharing tools, custom views, and tailored alerts encourage communication and easy collaboration.

We had five full-time employees and outside consultants doing what we can now do with Context Matters.”
— Pharmaceutical Customer

See how our customers are solving real world problems.